Cargando…
Morphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report
At present, the world is undergoing successive waves of the COVID-19 pandemic. When COVID-19 becomes severe, it causes respiratory failure and symptoms of dyspnoea. The patient’s dyspnoea worsens to the IPOS of 3. One COVID-19 patient admitted to our medical institution developed severe illness char...
Autores principales: | Tanaka-Yagi, Yukako, Yamaguchi, Takashi, Matsuda, Yoshinobu, Mori, Masanori, Ikari, Tomoo, Miwa, Satoru, Suzuki, Kozue, Tachikawa, Ryo, Nakata, Kyosuke, Kanatani, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168286/ https://www.ncbi.nlm.nih.gov/pubmed/35673688 http://dx.doi.org/10.25259/IJPC_132_2021 |
Ejemplares similares
-
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
por: Mori, Masanori, et al.
Publicado: (2022) -
Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians
por: Matsuda, Yoshinobu, et al.
Publicado: (2020) -
Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study
por: Taniguchi, Yoshihiko, et al.
Publicado: (2022) -
Research policy in supportive care and palliative care for cancer dyspnea
por: Matsuda, Yoshinobu, et al.
Publicado: (2021) -
Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
por: Mori, Masanori, et al.
Publicado: (2020)